Eidos Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Eidos Therapeutics, Inc.
Quantité totale PI 17
Rang # Quantité totale PI 90 206
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 239
Symbole boursier EIDX (nasdaq)
ISIN US28249H1041
Capitalisation 2,900M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

10 0
3 0
4 0
0
 
Dernier brevet 2025 - Formulations of ag10
Premier brevet 2018 - Process for preparing ag-10, its...

Derniers inventions, produits et services

2024 Invention Methods of treating ttr amyloidosis using ag10. Described herein are methods for treating transt...
Invention Formulations of ag10. The present disclosure provides high-load tablet formulations of AG10 or a...
Invention Potent transthyretin (ttr) stabilization in ttr amyloidosis patients receiving acoramidis. Descri...
Invention Processes for preparing ag-10, its intermediates, and salts thereof. Provided herein are improve...
2022 Invention Formulations of ag10. The present disclosure provides high-load tablet formulations of AG10 or a ...
2021 Invention Processes for preparing ag-10, its intermediates, and salts thereof. Provided herein are improved...
Invention Methods of treating ttr amyloidosis using ag10. Described herein are methods for treating transth...
2018 Invention Process for preparing ag-10, its intermediates, and salts thereof. Provided herein are improved p...